{"product_id":"nanocarriers-for-drugtargeting-brain-tumors-9780323907736","title":"Nanocarriers for Drug-Targeting Brain Tumors","description":"\u003cp\u003e\u003c\/p\u003e\u003cblockquote\u003eNanocarriers for Drug-Targeting Brain Tumors is a book that discusses the design and development of nanocarriers for targeting drugs to the brain. It presents case studies and the mechanism of action of nanocarriers in drug targeting, helping researchers and clinicians understand the effectiveness of these carriers in reducing toxicity and improving drug effectiveness. \u003c\/blockquote\u003e\u003cp\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e: Paperback \/ softback\u003cbr\u003e\u003cstrong\u003eLength\u003c\/strong\u003e: 856 pages\u003cbr\u003e\u003cstrong\u003ePublication date\u003c\/strong\u003e: 17 June 2022\u003cbr\u003e\u003cstrong\u003ePublisher\u003c\/strong\u003e: Elsevier - Health Sciences Division\u003cbr\u003e\u003c\/p\u003e \u003cp\u003eNanocarriers for Drug-Targeting Brain Tumors delves into a comprehensive exploration of various types of nanocarriers and their meticulous design and development for effectively delivering drugs to the brain. This invaluable resource also presents compelling case studies, shedding light on the mechanism of action of nanocarriers in precisely targeting specific sites within the brain. By providing researchers and clinicians with a deep understanding of the design, development, and mechanism of action of nanocarriers, this book serves as a valuable tool for advancing their knowledge and expertise in this field.\u003cbr\u003e\u003cbr\u003eGiven the persistent challenges posed by brain tumors, which remain a significant global health concern and pose considerable difficulties in drug targeting, conventional dosage forms have proven to be inadequate and have raised concerns regarding side effects. In response to these challenges, functionalized nanocarriers emerge as a promising solution. These nanocarriers possess the unique ability to address these problems effectively. Furthermore, the targeted delivery of nanocarriers is highly favored for reducing toxicity and enhancing the efficacy of drugs, thereby improving patient outcomes.\u003cbr\u003e\u003cbr\u003eHowever, it is crucial to gain a deeper understanding of the design and development of formulations alongside the mechanism of action of nanocarriers in their targeted delivery to the brain. This knowledge gap underscores the need for further research and exploration in this domain to unlock the full potential of nanocarriers in brain tumor therapy.\u003c\/p\u003e\u003cp\u003e\u003cbr\u003e\u003cstrong\u003eDimension\u003c\/strong\u003e: 235 x 191 (mm)\u003cbr\u003e\u003cstrong\u003eISBN-13\u003c\/strong\u003e: 9780323907736\u003c\/p\u003e","brand":"Shulph Ink","offers":[{"title":"Paperback \/ softback","offer_id":44096404685050,"sku":"9780323907736","price":272.25,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/4297\/2845\/products\/1657291942424_book.jpg?v=1657606123","url":"https:\/\/shulphink.com\/products\/nanocarriers-for-drugtargeting-brain-tumors-9780323907736","provider":"Shulph Ink","version":"1.0","type":"link"}